# A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese Participants

> **NCT06869018** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 92 (actual)

## Conditions studied

- Healthy
- Type 2 Diabetes Mellitus (T2D)

## Interventions

- **DRUG:** LY3549492
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06869018
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-05-07
- **Primary completion:** 2026-03-02
- **Final completion:** 2026-03-02
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06869018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06869018, "A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06869018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*